I agree that this site is using cookies. You can find further informations here.
X
Villaruz, L.C.
128  results:
Search for persons X
?
1

Correction: Combination of Itacitinib or Parsaclisib with P..:

Munster, Pamela ; Iannotti, Nicholas ; Cho, Daniel C....
Cancer Research Communications.  4 (2024)  3 - p. 785-785 , 2024
Link: https://doi.org/10.1158/..
 
?
2

104TiP Phase Ib/IIa study of ATR inhibitor tuvusertib + ant..:

Paz-Ares, L. ; Cappuzzo, F. ; Yamamoto, N....
ESMO Open.  9 (2024)  - p. 102683 , 2024
Link: https://doi.org/10.1016/..
 
?
3

Tackling KRASG12C-mutated non-small-cell lung cancer: itera..:

Luo, Jia ; Villaruz, Liza C
The Lancet Respiratory Medicine.  , 2024
Link: https://doi.org/10.1016/..
 
?
4

P2.06-12 The Safety and Efficacy of Durvalumab as 1st Line ..:

Shaverdashvili, K. ; Reyes, V. ; Wang, H....
Journal of Thoracic Oncology.  18 (2023)  11 - p. S322 , 2023
Link: https://doi.org/10.1016/..
 
?
5

Phase I Study of Entinostat, Atezolizumab, Carboplatin, and..:

Gentzler, Ryan D ; Villaruz, Liza C ; Rhee, John C...
The Oncologist.  28 (2023)  11 - p. 1007-e1107 , 2023
Link: https://doi.org/10.1093/..
 
?
6

Emerging therapeutic strategies for enhancing sensitivity a..:

Villaruz, Liza C. ; Blumenschein Jr., George R. ; Otterson, Gregory A..
Cancer.  129 (2023)  9 - p. 1319-1350 , 2023
Link: https://doi.org/10.1002/..
 
?
7

Top 10 public health challenges to track in 2023: Shifting ..:

Lucero‐Prisno III, Don Eliseo ; Shomuyiwa, Deborah Oluwaseun ; Kouwenhoven, M. B. N....
Public Health Challenges.  2 (2023)  2 - p. , 2023
Link: https://doi.org/10.1002/..
 
?
8

EP10.01-03 A Phase 1/2 Study of REGN5093-M114, a METxMET An..:

Drilon, A. ; Awad, M.M. ; Camidge, D.R....
Journal of Thoracic Oncology.  18 (2023)  11 - p. S602-S603 , 2023
Link: https://doi.org/10.1016/..
 
?
9

OA02.04 Phase 1/2 Randomized Trial of Anetumab Ravtansine a..:

Mansfield, A.S. ; Yin, J.V. ; Bradbury, P....
Journal of Thoracic Oncology.  18 (2023)  11 - p. S47 , 2023
Link: https://doi.org/10.1016/..
 
?
10

Design of Charge Pump for Low Power, Wide Range PLL in 65nm..:

, In: 2023 22nd International Symposium on Communications and Information Technologies (ISCIT),
Cuizon, Edwin C. ; Yuson, Marven A. ; Caberos, Aileen B... - p. 1-5 , 2023
Link: https://doi.org/10.1109/..
 
?
11

A single-arm, multicenter, phase II trial of osimertinib in..:

Villaruz, L.C. ; Wang, X. ; Bertino, E.M....
ESMO Open.  8 (2023)  2 - p. 101183 , 2023
Link: https://doi.org/10.1016/..
 
?
12

Combination of Itacitinib or Parsaclisib with Pembrolizumab..:

Munster, Pamela ; Iannotti, Nicholas ; Cho, Daniel C....
Cancer Research Communications.  3 (2023)  12 - p. 2572-2584 , 2023
Link: https://doi.org/10.1158/..
 
?
13

PP01.50 EMERGE-201: Phase 2 Basket Study of Lurbinectedin M..:

Spigel, D. ; Galsky, M.D. ; Heeke, A.L....
Journal of Thoracic Oncology.  18 (2023)  3 - p. e31 , 2023
Link: https://doi.org/10.1016/..
 
?
14

122P Casdozokitug (casdozo, SRF388), a first-in-class IL-27..:

Marron, T.U. ; Naing, A. ; Mantia, C....
Immuno-Oncology and Technology.  20 (2023)  - p. 100594 , 2023
Link: https://doi.org/10.1016/..
 
?
15

A phase II clinical trial evaluating the safety and efficac..:

Shaverdashvili, Khvaramze ; Reyes, Vincent ; Wang, Hong...
eClinicalMedicine.  66 (2023)  - p. 102317 , 2023
Link: https://doi.org/10.1016/..
 
1-15